LATAM is a region that offers unique advantages for conducting Clinical Trials due to its substantial population, enabling rapid patient enrollment and high retention rates. Additionally, the relatively lower prevalence of competing studies across various therapeutic areas enhances the feasibility of trials. However, navigating varying regulations and approval timelines across countries may lead to trial delays and data inconsistencies.

To overcome these challenges, sponsors must be well-prepared to collaborate with diverse entities, including government bodies, international agencies, and local ethics committees, addressing regulatory and ICH-
GCP matters.

PRS, leveraging a decade of experience in the Chilean market, emerges as the ideal partner for this task. We accompany our clients, ensuring the successful implementation and development of clinical studies in our region.